Takayuki Shiroyama (Oncology Center of Osaka University Hospital), Atsushi Kumanogoh (Graduate School of Medicine, Osaka University/IFReC) and the research group showed that sarcopenia at baseline as determined using computed tomography is a significant predictor of worse outcome in patients with advanced NSCLC receiving PD-1 blockade.

Figure: Evaluation of muscle mass by abdominal CT.
The large psoas muscle is shown in green.
The muscle mass is sufficient (L), whereas the mass decrease (R).

Commentary(PDF)


Article (External Link)

Contact:

Atsushi Kumanogoh（Immunopathology）

+81-6-6879-3831
kumanogoimed3.med.osaka-u.ac.jp

Immunology Frontier Research Center, Osaka University (WPI-IFReC)